Cellular determinants of the mutational specificity of 1-nitroso-6-nitropyrene and 1-nitroso-8-nitropyrene in the lacI gene of Escherichia coli.
We have characterized 202 lacI(-) mutations, and 158 dominant lacI(-d) mutations following treatment of Escherichia coli strains NR6112 and EE125 with 1-nitroso-6-nitropyrene (1,6-NONP), an activated metabolite of the carcinogen 1,6-dinitropyrene. In all, 91% of the induced point mutations occurred at G:C residues. The -(G:C) frameshifts were the dominant mutational class in the lacI(-) collections of both NR6112 and EE125, and in the lacI(-d) collection of NR6112. Frameshift mutations occurred preferentially in runs of guanine residues, and their frequency increased with the length of the reiterated sequence. In strain EE125, which contained the plasmid pKM101, there was a marked stimulation in the frequency of base substitution mutations that was particularly apparent in the lacI(-d) collection. This study completes a comprehensive analysis of 1194 lacI(-) and 348 lacI(-d) mutations induced by either 1,6-NONP or its positional isomer 1-nitroso-8-nitropyrene (1,8-NONP) in strains of E. coli that differ with regard to their ability to carry out nucleotide excision repair and/or their ability to express the translesion synthesis DNA polymerase RI (MucAB) encoded by plasmid pKM101. Among the mutations are 763 frameshift mutations, 367 base substitutions and 47 deletions; these mutations have been characterized at more than 300 distinct sites in the lacI gene. Our studies provide detailed insight into the DNA sequence alterations and mutational mechanisms associated with dinitropyrene mutagenesis. We review the mutational spectra, and discuss cellular lesion repair or tolerance mechanisms that modulate the observed mutational specificity.
Lambert
I B
IB
Biology Department, Carleton University, 1125 Colonel By Drive, Ont., K1S 5B6, Ottawa, Canada. ilambert@ccs.carleton.ca
Carroll
C
C
Laycock
N
N
Koziarz
J
J
Lawford
I
I
Duval
L
L
Turner
G
G
Booth
R
R
Douville
S
S
Whiteway
J
J
Nokhbeh
M R
MR
D019943:Amino Acid Substitution; D001426:Bacterial Proteins / Q000235:genetics* / Q000378:metabolism; D001483:Base Sequence; D002273:Carcinogens / Q000378:metabolism / Q000633:toxicity; D004260:DNA Repair; D004926:Escherichia coli / Q000187:drug effects* / Q000235:genetics* / Q000378:metabolism; D029968:Escherichia coli Proteins; D016368:Frameshift Mutation; D005798:Genes, Bacterial; D056968:Lac Repressors; D009153:Mutagens / Q000633:toxicity*; D009154:Mutation; D009603:Nitroso Compounds / Q000633:toxicity*; D010957:Plasmids / Q000235:genetics; D017354:Point Mutation; D011721:Pyrenes / Q000378:metabolism / Q000633:toxicity*; D012097:Repressor Proteins / Q000235:genetics*
D001426:Bacterial Proteins; D002273:Carcinogens; D029968:Escherichia coli Proteins; D056968:Lac Repressors; C539064:LacI protein, E coli; D009153:Mutagens; D009603:Nitroso Compounds; D011721:Pyrenes; D012097:Repressor Proteins; C047861:1-nitro-8-nitrosopyrene; C047860:1-nitro-6-nitrosopyrene; C068606:mucAB protein, E coli; C033309:1,6-dinitropyrene